Bill Sibold
Chief Executive Officer
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Madrigal Pharmaceuticals, Inc. (MDGL) | President and Chief Executive Officer | $918,531 | $19,206,341 |
| 2024 | Madrigal Pharmaceuticals, Inc. (MDGL) | President and Chief Executive Officer | $889,583 | $12,214,250 |
| 2023 | Madrigal Pharmaceuticals, Inc. (MDGL) | President and Chief Executive Officer | $275,400 | $32,268,400 |
Executive changes
Earnings-call appearances
-
Canaccord Genuity 46th Annual Growth Conference2026-08-11
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Q2 2026 Earnings Call2026-07-30
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-06
Madrigal Pharmaceuticals, Inc. (MDGL)
-
TD Cowen 46th Annual Health Care Conference2026-03-03
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-19
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-01
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-02-26
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-10-31
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-07
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-07
Madrigal Pharmaceuticals, Inc. (MDGL)